EP3297631
NK-1/NK-3 viðtakablokki til meðferðar á hitakófum
Status:
EP einkaleyfi: Leiðrétt þýðing á staðfestu EP einkaleyfiEP appl. date:
16.5.2016EP published:
4.9.2019EP application number:
16723107.5
EP translation filed:
3.10.2019Grant published:
15.1.2020EPO information:
European Patent Register
Max expiry date:
15.5.2036Expiry date:
16.5.2026Next due date:
31.5.2026
Title:
NK-1/NK-3 RECEPTOR ANTAGONIST FOR THE TREATMENT OF HOT FLUSHES
Timeline
Today
16.5.2016EP application
4.9.2019EP Publication
3.10.2019Translation submitted
15.1.2020Registration published
16.5.2026Expires
Owner
Name:
KaNDy Therapeutics LimitedAddress:
400 South Oak Way, RG2 6AD, Reading, Berkshire, GB
Inventor
Name:
TROWER, MikeAddress:
StevenageHertfordshire SG1 2FX, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562162870 PDate:
18.5.2015Country:
US
Supplementary protection
SPC number:
SPC539
Classification
Categories:
A61K 31/5383, A61P 5/24, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 30.4.2020
Expires: 16.5.2021
Payer: Patice ehf.
Number: 6
Paid: 26.4.2021
Expires: 16.5.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 28.4.2022
Expires: 16.5.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 28.4.2023
Expires: 16.5.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 23.4.2024
Expires: 16.5.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 13.5.2025
Expires: 16.5.2026
Payer: Árnason Faktor ehf.